Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 7,774 | 12,513 | 8,042 | 9,675 | 7,857 |
| Operating Income | -7,774 | -12,513 | -8,042 | -9,675 | -7,857 |
| Interest Expense | 0 | 0 | 0 | -64 | 46 |
| Other Income | 215 | 226 | 247 | 0 | 0 |
| Pre-tax Income | -7,559 | -12,288 | -7,795 | -9,611 | -7,903 |
| Net Income Continuous | -7,559 | -12,288 | -7,795 | -9,611 | -7,903 |
| Net Income | $-7,559 | $-12,288 | $-7,795 | $-9,611 | $-7,903 |
| EPS Basic Total Ops | -8.16 | -80.32 | -399.90 | -2,086.96 | -5,829.09 |
| EPS Basic Continuous Ops | -8.16 | -80.32 | -399.88 | -2,086.27 | -4,406.43 |
| EPS Diluted Total Ops | -8.16 | -80.32 | -399.90 | -2,086.96 | -5,829.09 |
| EPS Diluted Continuous Ops | -8.16 | -80.32 | -399.88 | -2,086.27 | -4,406.43 |
| EPS Diluted Before Non-Recurring Items | N/A | -80.30 | -400.30 | -2,086.96 | -5,829.09 |
| EBITDA(a) | $-7,774 | $-12,513 | $-8,042 | $-9,675 | $-7,843 |